Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology, By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)

Report
220 Pages
October 2023
Region: Global
Azoth Analytics
ID: 5886437

The publisher has released a research report titled “Global Core Clinical Molecular Diagnostics Market (2023 Edition)” which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 11 countries (United States, Canada, United Kingdom, Germany, Italy, France, Spain, China, India, Japan, Australia). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.

During the forecast period, 2024-2029, the Global Core Clinical Molecular Diagnostics market is expected to grow at a CAGR of 10.7%. The Global Core Clinical Molecular Diagnostics Market is expected to generate USD 11.04 billion by the end of 2029, up from USD 4.9 Billion in 2022.

Clinical Molecular diagnostics is a rapidly expanding market that encompasses a wide range of applications, including infectious illnesses, cancer, hematopathology, clinical chemistry, and clinical genetics. The increasing prevalence of chronic diseases coupled with the growing demand for advanced diagnostic solutions for early disease detection are driving the market growth.

Additionally, the increasing awareness of personalized treatment and direct-to-consumer genetic testing is also supporting the market growth.

Moreover, the rising global prevalence of infectious diseases has significantly contributed to the demand for clinical molecular diagnostics solutions, wherein polymerase chain reaction (PCR) testing has emerged as the primary method for detecting COVID-19. The application of polymerase chain reaction (PCR) testing has played a significant role in enhancing the field of molecular diagnostics for infectious diseases, specifically in nucleic acid-based methodologies. As a result, this particular segment has emerged as one of the most prominent segments within the core clinical molecular diagnostics market.

Scope of the Report

The report analyses the Core Clinical Molecular Diagnostics Market by Value (USD Billion).
The report presents the analysis of Core Clinical Molecular Diagnostics Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
The report analyses the Core Clinical Molecular Diagnostics Market by Application (Infectious disease and blood screening, Genetic testing, Cancer Screening Other Applications).
The report analyses the Core Clinical Molecular Diagnostics Market by Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Other Technologies).
The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by Region, by Application & by Technologies.
Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report Merck Group (SigmaAldrich Co., LLC), F. Hoffmann-La Roche AG, Agilent technologies, PerkinElmer Inc., Abbott Laboratories, QIAGEN, Thermo Fisher Scientific, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation.

1. Market Background

1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Strategic Recommendations

2.1 Integration of AI and Data Analytics to deliver highly accurate and rapid results
2.2 Partnerships with Academic Institutes

3. Global Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

3.1 Age-standardised cancer incidence rate, 2020
3.2 SARS-Cov-2 Tests: Volumes 2020
3.3 Molecular diagnostics undergoing Clinical trials
3.4 Global Core Clinical Molecular Diagnostics Market : Dashboard
3.5 Global Core Clinical Molecular Diagnostics Market: Market Value Assessment, 2019-2029 (USD Billion)
3.6 Impact of COVID-19 on Global Core Clinical Molecular Diagnostics Market
3.7 Global Core Clinical Molecular Diagnostics Market Segmentation: By Application
3.7.1 Global Core Clinical Molecular Diagnostics Market, By Application Overview
3.7.2 Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.3 Global Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.4 Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.5 Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
3.8 Global Core Clinical Molecular Diagnostics Market Segmentation: By Technology
3.8.1 Global Core Clinical Molecular Diagnostics Market, By Technology Overview
3.8.2 Global Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.3 Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.4 Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.5 Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global Core Clinical Molecular Diagnostics Market, Region Analysis

4.1 Regional Coverage of the Study

5. Americas Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

5.1 Americas Core Clinical Molecular Diagnostics Market: Snapshot
5.2 Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas Core Clinical Molecular Diagnostics Market: Key Factors
5.4 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Application
5.4.1 Americas Core Clinical Molecular Diagnostics Market, By Application Overview
5.4.2 Americas Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.3 Americas Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.4 Americas Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.5 Americas Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Technology
5.5.1 Americas Core Clinical Molecular Diagnostics Market, By Technology Overview
5.5.2 Americas Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Core Clinical Molecular Diagnostics Market Segmentation : By Country
5.6.1 United States Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.1.1 United States Core Clinical Molecular Diagnostics Market, By Application
5.6.1.2 United States Core Clinical Molecular Diagnostics Market, By Technology
5.6.2 Canada Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.2.1 Canada Core Clinical Molecular Diagnostics Market, By Application
5.6.2.2 Canada Core Clinical Molecular Diagnostics Market, By Technology
5.6.3 Rest of Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.3.1 Rest of Americas Core Clinical Molecular Diagnostics Market, By Application
5.6.3.2 Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology

6. Europe Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

6.1 Europe Core Clinical Molecular Diagnostics Market: Snapshot
6.2 Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe Core Clinical Molecular Diagnostics Market: Key Factors
6.4 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Application
6.4.1 Europe Core Clinical Molecular Diagnostics Market, By Application Overview
6.4.2 Europe Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.3 Europe Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.4 Europe Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.5 Europe Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
6.5 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Technology
6.5.1 Europe Core Clinical Molecular Diagnostics Market, By Technology Overview
6.5.2 Europe Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.5 Europe Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Core Clinical Molecular Diagnostics Market Segmentation : By Country
6.6.1 France Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.1.1 France Core Clinical Molecular Diagnostics Market, By Application
6.6.1.2 France Core Clinical Molecular Diagnostics Market, By Technology
6.6.2 United Kingdom Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 United Kingdom Core Clinical Molecular Diagnostics Market, By Application
6.6.2.2 United Kingdom Core Clinical Molecular Diagnostics Market, By Technology
6.6.2 Italy Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 Italy Core Clinical Molecular Diagnostics Market, By Application
6.6.2.2 Italy Core Clinical Molecular Diagnostics Market, By Technology
6.6.3 Spain Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.3.1 Spain Core Clinical Molecular Diagnostics Market, By Application
6.6.3.2 Spain Core Clinical Molecular Diagnostics Market, By Technology
6.6.4 Germany Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.4.1 Germany Core Clinical Molecular Diagnostics Market, By Application
6.6.4.2 Germany Core Clinical Molecular Diagnostics Market, By Technology
6.6.5 Rest of Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.5.1 Rest of Europe Core Clinical Molecular Diagnostics Market, By Application
6.6.5.2 Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology

7. Asia-Pacific Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

7.1 Asia-Pacific Core Clinical Molecular Diagnostics Market: Snapshot
7.2 Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia-Pacific Core Clinical Molecular Diagnostics Market: Key Factors
7.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Application
7.4.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application Overview
7.4.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
7.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Technology
7.5.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology Overview
7.5.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation : By Country
7.6.1 China Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.1.1 China Core Clinical Molecular Diagnostics Market, By Application
7.6.1.2 China Core Clinical Molecular Diagnostics Market, By Technology
7.6.2 Japan Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.2.1 Japan Core Clinical Molecular Diagnostics Market, By Application
7.6.2.2 Japan Core Clinical Molecular Diagnostics Market, By Technology
7.6.3 India Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.3.1 India Core Clinical Molecular Diagnostics Market, By Application
7.6.3.2 India Core Clinical Molecular Diagnostics Market, By Technology
7.6.4 Australia Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.4.1 Australia Core Clinical Molecular Diagnostics Market, By Application
7.6.4.2 Australia Core Clinical Molecular Diagnostics Market, By Technology
7.6.5 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.5.1 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application
7.6.5.2 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology

8. Middle-East & Africa Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

8.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Snapshot
8.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Key Factors
8.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Application
8.4.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Application Overview
8.4.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Technology
8.5.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Technology Overview
8.5.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

9.1 Impact assessment of Market Dynamics on Global Core Clinical Molecular Diagnostics Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Porter’s Five Forces Analysis

10.1 Porter’s Five Forces Model

11. Competitive Positioning

11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Core Clinical Molecular Diagnostics Market
11.4 Company Profiles
11.4.1 Merck Group (SigmaAldrich Co., LLC)
11.4.2 F. Hoffmann-La Roche AG
11.4.3 Agilent technologies
11.4.4 PerkinElmer Inc.
11.4.5 Abbott Laboratories
11.4.6 QIAGEN
11.4.7 Thermo Fisher Scientific
11.4.8 Becton, Dickinson and Company
11.4.9 Hologic, Inc.
11.4.10 Danaher Corporation

12. Abbreviations

List of Figures

Figure 1: Age-standardised cancer incidence rate, 2020
Figure 2: Global Core Clinical Molecular Diagnostics Market Size, By Value, 2019-2022 (USD Billion)
Figure 3: Global Core Clinical Molecular Diagnostics Market Size, By Value, 2023-2029 (USD Billion)
Figure 4: Global Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 5: Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 6: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Infectious disease and blood screening, 2019-2029 (USD Billion)
Figure 7: Global Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 8: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Genetic testing, 2019-2029 (USD Billion)
Figure 9: Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 10: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Cancer Screening, 2019-2029 (USD Billion)
Figure 11: Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 12: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Other Applications, 2019-2029 (USD Billion)
Figure 13: Global Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 14: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By In situ hybridization, 2019-2029 (USD Billion)
Figure 15: Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 16: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Polymerase Chain Reaction, 2019-2029 (USD Billion)
Figure 17: Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 18: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Sequencing, 2019-2029 (USD Billion)
Figure 19: Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 20: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Others, 2019-2029 (USD Billion)
Figure 21: Americas Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 22: Americas Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 23: Americas Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 24: Americas Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 25: Americas Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 26: Americas Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: Americas Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 28: Americas Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 29: Americas Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 30: Americas Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 31: United States Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 32: United States Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 33: United States Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 34: United States Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 35: Canada Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 36: Canada Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 37: Canada Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 38: Canada Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 39: Rest of Americas Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 40: Rest of Americas Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 41: Rest of Americas Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 42: Rest of Americas Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 43: Europe Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 44: Europe Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 45: Europe Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 46: Europe Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 47: Europe Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 48: Europe Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 49: Europe Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 50: Europe Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 51: Europe Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 52: Europe Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 53: France Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 54: France Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 55: France Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 56: France Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 57: United Kingdom Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 58: United Kingdom Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 59: United Kingdom Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 60: United Kingdom Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 61: Italy Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 62: Italy Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 63: Italy Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 64: Italy Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 65: Spain Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 66: Spain Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 67: Spain Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 68: Spain Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 69: Germany Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 70: Germany Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 71: Germany Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 72: Germany Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 73: Rest of Europe Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 74: Rest of Europe Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 75: Rest of Europe Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 76: Rest of Europe Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 77: Asia Pacific Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 78: Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 79: Asia Pacific Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 80: Asia Pacific Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)

List of Tables

Table A1: SARS-Cov-2 Tests: Volumes 2020
Table A2: Molecular diagnostics undergoing Clinical trials
Table A3: United States Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A4: United States Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A5: United States Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A6: United States Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A7: Canada Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A8: Canada Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A9: Canada Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A10: Canada Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A11: Rest of Americas Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A12: Rest of Americas Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A13: Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A14: Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A15: France Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A16: France Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A17: France Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A18: France Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A19: United Kingdom Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A20: United Kingdom Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table Information

Report Attribute	Details
No. of Pages	220
Published	October 2023
Forecast Period	2024 - 2029
Estimated Market Value ( USD ) in 2024	$ 6.64 Billion
Forecasted Market Value ( USD ) by 2029	$ 11.04 Billion
Compound Annual Growth Rate	10.7%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF And Excel

Enterprise License PDF And Excel

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a single user license, allowing one user access to the product.	€2338EUR$2,450USD£1,958GBP
ENTERPRISE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is an enterprise license, allowing all employees within your organization access to the product.	€2815EUR$2,950USD£2,358GBP

Scope of the Report

Table of Contents

Table Information

Related Topics

Related Reports

Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments), Technology (PCR, INAAT), Application (Oncology, Genetic Testing), Test Location, and Segment Forecasts, 2024-2030

U.S. Molecular Diagnostics Market Size, Share & Trends Analysis Report By Disease (Healthcare-associated Infections, Respiratory), By End-use (Hospital Core Laboratory, Decentralized Test Sites), And Segment Forecasts, 2023 - 2030

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030

Molecular Diagnostics

Point-of-Care Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029